The IOPC is the leading event at the forefront of innovation, research, and novel developments in oligonucleotides and peptides.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

CPHI Korea is a dynamic meeting place where pharmaceutical suppliers, purchasers and decision makers get together for three days of uninterrupted business. Exhibiting companies showcase products from across the entire pharma supply chain.

RNA Leaders is the #1 must-attend event focused on RNA medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccines.

The Boulder Peptide Symposium is the only conference focused solely on the pharmaceutical development of peptide therapeutics. The conference seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics.

CPHI Milan unites industry leaders, pharma professionals, and businesses of all sizes under one roof for three days of powerful connection and collaboration. This is the event to witness emerging pharma trends, discover innovative solutions and products to stay in front of the marketplace, and drive your business forward.

Launched in 1986, BioJapan is Asia's premier bio-industry partnering event. As the world’s longest-running biotech exhibition, BioJapan continues to drive innovation and collaboration in the industry through its comprehensive event ecosystem, seminars, and partnering programs.

The Peptide Therapeutics Symposium was established in 2005 as an annual scientific meeting that brings together world leaders in peptide research from academia and the biopharmaceutical industries.

Access new data and case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market.

Dive into Joseph Denby's presentation at NextGen Biomed 2026, where he shares a case study on delivering sustainable, efficient peptide manufacturing on scale through our advanced SPPS process optimizations.

Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.

Watch Tim Nieters, MBA present a case study at TIDES USA 2024, showcasing process development & GMP manufacturing of DOTAGA-labeled peptide & POC-based products.

This presentation will review new USP recommendations in the context of existing regulatory guidance, with particular focus on peptide-related impurities, their identification...

This presentation will focus on the development of the latest GLP-1 mimetics and GLP-1/GIP dual agonists, with unparalleled efficacy and ease of delivery.

Peptide receptor radionuclide therapy (PRRT) is a targeted therapeutic strategy that uses peptides to deliver cytotoxic radiation levels to specific receptors overexpressed in cancer cells. This case study presents a manufacturing process for DOTAGA-Labeled urea-based peptide PSMA inhibitor API, DOTAGA-(I-y)fk(Sub-KuE).